PRAME-TCR therapy (controllable)

PRAME-targeted T-cell receptor therapy · Bellicum Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PRAME-TCR therapy (controllable), covering 2023-10-05 to 2023-10-05. Get the full timeline:

Most recent: Clinical Trial Update: Safety & Activity of Controllable PRAME-TCR Therapy in Previously Treated AML/MDS or Metastatic Uveal Melanoma [Phase 1, Phase 2]

See pricing